Insider Transactions in Q1 2023 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2023
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
537
-0.2%
|
$9,666
$18.24 P/Share
|
|
Jan 26
2023
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,156
-3.97%
|
$182,808
$18.51 P/Share
|
|
Jan 11
2023
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
44,568
-7.24%
|
$668,520
$15.93 P/Share
|
|
Jan 11
2023
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,510
-0.83%
|
$67,650
$15.95 P/Share
|
|
Jan 11
2023
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
60,490
-7.72%
|
$907,350
$15.98 P/Share
|
|
Jan 11
2023
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,021
-0.4%
|
$64,336
$16.8 P/Share
|